expert comment: the card trial | silke gillessen
Published 4 years ago • 287 plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
3:09
expert comment: the profound trial | eleni efstathiou
-
10:26
expert comment: antiandrogens in nonmetastatic crpc | tomasz beer
-
0:33
expert discusses toxicity results in card study
-
4:54
trials on trial - arches
-
0:42
oliver sartor, md, on impressions of the card study investigating the role of cabazitaxel in mcrpc
-
5:33
cancer immune checkpoint inhibitors
-
30:15
understanding stomach cancer: expert q&a
-
22:41
gastric cancer – please participate in our 3-minute survey below!
-
1:23
the role of immune checkpoint inhibitors in mcrpc
-
14:30
expert video viewpoints on castration-resistant prostate cancer - section 3
-
13:51
eautv: gu cancers at eau23
-
3:04
researcher comment: apalutamide addition improves metastatic cspc survival | axel merseburger
-
4:25
researcher comment: the therap trial | michael hofman
-
16:00
silke gillessen, st. gallen, ch
-
2:59
niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer
-
13:17
expert video viewpoints on castration-resistant prostate cancer - section 1
-
15:13
expert video viewpoints on castration-resistant prostate cancer - section 2
-
1:22
cabazitaxel improves rpfs in patients with mcrpc
-
2:04
dr. beer on the design and results of the prevail trial
-
4:50
card trial: cabazitaxel after ar-targeted therapy in mcspc
-
0:34
discussing the safety profile of cabazitaxel in mcrpc